Long acting epoetin alfa biobetter - UBI Pharma
Alternative Names: Long acting EPO - UBI Pharma; UB-852Latest Information Update: 02 Jan 2024
At a glance
- Originator UBI Pharma
- Class Antianaemics; Biobetters; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Anaemia